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Background: Zimbabwe is among the 22 Tuberculosis (TB) high burden countries worldwide and runs a
well-established, standardized recording and reporting system on case finding and treatment outcomes. During TB
treatment, patients transfer-out and transfer-in to different health facilities, but there are few data from any national
TB programmes about whether this process happens and if so to what extent. The aim of this study therefore was
to describe the characteristics and outcomes of TB patients that transferred into Harare City health department
clinics under the national TB programme. Specific objectives were to determine i) the proportion of a cohort of TB
patients registered as transfer-in, ii) the characteristics and treatment outcomes of these transfer-in patients and
iii) whether their treatment outcomes had been communicated back to their respective referral districts after
completion of TB treatment.
Methods: Data were abstracted from patient files and district TB registers for all transfer-in TB patients registered
from January to December 2010 within Harare City. Descriptive statistics were calculated.
Results: Of the 7,742 registered TB patients in 2010, 263 (3.5%) had transferred-in: 148 (56%) were males and
overall median age was 33 years (IQR, 26–40). Most transfer-in patients (74%) came during the intensive phase of
TB treatment, and 58% were from rural health-facilities. Of 176 patients with complete data on the time period
between transfer-in and transfer-out, only 85 (48%) arrived for registration in Harare from referral districts within
1 week of being transferred-out. Transfer-in patients had 69% treatment success, but in 21% treatment outcome
status was not evaluated. Overall, 3/212 (1.4%) transfer-in TB patients had their TB treatment outcomes reported
back to their referral districts.
Conclusion: There is need to devise better strategies of following up TB patients to their referral Directly Observed
Treatment (DOT) centres from TB diagnosing centres to ensure that they arrive promptly and on time. Recording
and reporting of information must improve and this can be done through training and supervision. Use of mobile
phones and other technology to communicate TB treatment outcomes back to the referral districts would seem
the obvious way to move forward on these issues.
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Tuberculosis (TB) remains a disease of major public
health concern the world over with most cases being
found in the South-East Asia, African and Western Paci-
fic regions [1]. Emergence of the human immunodefi-
ciency virus (HIV) epidemic has fuelled the TB epidemic
worldwide, with one in ten TB cases in 2010 being esti-
mated to be HIV-positive [1]. The African region has
been the worst affected by the HIV epidemic and
accounts for over 80% of the global HIV-TB burden [1].
Zimbabwe has not been spared as it is one of the
22 World Health Organisation (WHO) high TB burden
countries [1] and currently has an HIV prevalence of
15.2% for the adult population [2].
The World Health Organization has for nearly
20 years implemented a Stop TB Strategy for global and
national TB control, and one of its cornerstones is a
standardised recording and reporting system. For smear-
positive pulmonary TB (PTB) patients, at the end of a
course of treatment there are 6 possible outcomes: cure,
treatment completed, failed, died, lost to follow up and
transferred out [3,4]. A transfer-out is a patient who
transfers from one reporting centre to another centre in
a different reporting district and for whom the treatment
outcome is unknown. This can be a sizeable problem:
for the 2.5 million new smear-positive PTB patients
registered in “DOTS” programmes globally in 2006,
3% or 75,000 patients were reported to be transferred
out [5].
For the same year, the transfer-out rates in the African
region were 4%, with individual countries reporting rates
of between 0% – 16% [4]. From the two most recent glo-
bal reports in 2010 and 2011[1,6], it is difficult to get a
good estimate of the transfer-out problem as this treat-
ment outcome category has been subsumed under a cat-
egory called “not evaluated”: for the 2009 global cohort
of treatment outcomes in new smear-positive PTB
patients, the “not evaluated” proportion was 4% of
2.6 million patients registered [1], and this group prob-
ably contained a high number of patients who had trans-
ferred out.
Every patient who transfers out from the original
registration unit should in theory “transfer-in” to a new
TB registration unit in a different reporting district.
However, the original registration unit maintains the re-
sponsibility for reporting on their treatment outcomes.
Patients who are transferred into Harare City from an-
other district carry with them a transfer out form from
the referral district, which includes details such as
patient name, referral hospital and district, sex, age,
treatment category, type of TB and transfer-out date.
These transfer-in patients are registered in the TB regis-
ter at either of 2 infectious disease hospitals before refer-
ral for DOT at their nearest municipal clinic. Uponcompletion of TB treatment, the national guidelines spe-
cify that the outcomes of these transfer-in patients be
routinely communicated back to the district from which
the patient was transferred.
District TB coordinators for each district also follow
up treatment outcomes of patients transferred out by
issuing a treatment outcome request form to the
transfer-in receiving health facility. If treatment out-
comes of patients transferred out are unknown when
cohort analysis is conducted, these patients have their
treatment outcomes recorded as “transfer-out”. Includ-
ing the treatment outcomes of patients transferred into
a district as part of that district’s cohort is not allowed
as this will result in more patients with treatment out-
comes than patients notified and registered for that
particular reporting period [3].
There are few data from national TB programmes
about whether or to what extent this process happens.
The aim of this study therefore was to describe the char-
acteristics and outcomes of TB patients that transferred
into Harare City health department clinics under the
national TB programme. Specific objectives were to
determine i) the proportion of a cohort of TB patients
registered as transfer-in, ii) the characteristics and treat-
ment outcomes of these transfer-in patients and iii)
whether their treatment outcomes had been communi-
cated back to their respective referral districts after com-
pletion of TB treatment.
Methods
Study design
This was a descriptive cross-sectional study design using
registers and treatment cards.
Study setting
This study was conducted in Harare, the capital city of
Zimbabwe which has an estimated population of around
1.6 million [7]. In Harare, National TB programme
services are offered under the city health department,
and hence the study included all 32 municipal clinics
and 2 infectious disease hospitals which offer general
health services integrated with TB treatment services [7].
The municipal clinics are partitioned into either the
southern or northern region, with each region consisting
of an infectious disease hospital in which TB diagnostic
services (smear microscopy and chest radiography) are
performed for the surrounding clinics.
General diagnosis and management of TB patients
In Zimbabwe, TB is diagnosed according to national
guidelines [3] which are based on the WHO TB treat-
ment guidelines [4]. Direct smear microscopy is the
main method for diagnosing pulmonary TB, whereby
suspected TB patients have their sputa collected at their
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smear microscopy to the infectious disease hospital in
their respective region. All confirmed TB patients are
treated using standardised anti-TB regimens according
to national [3] and international guidelines [4].
Monitoring is done clinically for smear-negative PTB
and EPTB patients whilst those with new smear-positive
PTB have sputum smears examined for acid-fast
bacilli at 2, 5 and 6 months. Those with previously trea-
ted sputum smear-positive PTB have sputum examined
at the end of 3,5 and 8 months. Smear-negative patients
who complete treatment and smear-positive patients
who complete treatment with or without negative
smears are regarded as “successfully completing treat-
ment”. Patients are offered HIV counselling and testing
(opt-out provider-initiated) upon diagnosis of TB, and
cotrimoxazole preventive therapy (CPT) is started toge-
ther with anti-TB treatment for TB/HIV co-infected
patients, provided there is no contra-indication. All
HIV-positive TB patients are eligible for antiretroviral
therapy (ART) initiation at Opportunistic Infections (OI)
/ART initiating clinics at either of the 2 hospitals com-










Category of TB New
(n=256) Retreatment TB
Type of new TB Smear-positive PTB
(n=216) Smear-negative PTB
EPTB
PTB smears not done








*Variables in the table above have varying totals because missing data was exclude
NB: Percentages may not always add up to 100 because of rounding off error.
HIV = human immunodeficiency virus; TB = tuberculosis; PTB = pulmonary TB, EPTBPatient sample
Data were collected for all TB patients that trans-
ferred into Harare City between 1 January 2010 and
31 December 2010 from TB registers at the two infec-
tious disease hospitals.
Data variables, data source and data collection
Patient data on those who transferred-in were abstracted
from the TB registers between January 2012 and
February 2012 using a data collection form, and variables
that were collected included:- TB registration number, sex,
age, type of TB, HIV status, TB treatment phase at time
of transferring, date of transfer-out from the districts,
date of transfer-in at the regional infectious disease
hospital and the TB treatment outcome. Patient data in
the TB registers were verified from individual patient
files stored at their respective hospitals, and these
patients were traced to their referral municipal clinics to
establish if they arrived and were registered. District TB
coordinators were also contacted by telephone to establish
if treatment outcomes of their patients that had been
transferred into Harare city had been communi-
cated back to them. Individual TB registration numbersvs. Non transfer-in patients TB patient in Harare City –





148 (56)) 3993 (55) 0.667
115 (44) 3276 (45)
21 (8) 777 (10.8) 0.025
36 (14) 657 (9.1)
160 (62) 4242 (58.8)
26 (10) 847 (11.7)
17 (7) 686 (9.5)
222 (87) 6603 (91.6) 0.016
34 (13) 606 (8.4)
67 (31) 1946 (29.5) 0.355
87 (40) 2949 (44.7)
26 (12) 595 (9.0)
36 (17) 1113 (16.9)
10 (34) 196 (32.3) >0.99
17 (59) 351 (57.9)
1 (3) 20 (3.3)
1 (3) 39 (6.4)
232 (95) 4605 (63.9) <0.01
11 (5) 2604 (36.1)
163 (71) 3847 (83.5) <0.01
67 (29) 758 (16.5)
d.
= extra-pulmonary TB.
Table 2 Characteristics of the Transfer process of
transfer-in TB patients in Harare City, Zimbabwe
Characteristic* (N=263) n (%)
Time period between transfer-out and transfer-in to hospitals in Harare City
(n=176)
< 8 days 85 (48)
8 – 31 days 70 (40)
>31days 21 (12)
Anti-TB treatment phase at time of transfer-in from the district (n=216)
Intensive phase 159 (74)
Continuation phase 57 (26)
Type of referral health facility from where patients were transferred-out
(n=212)
rural mission hospital 88 (42)
district hospital 52 (25)
urban municipal clinic 51 (25)
rural clinic 4 (2)
prison facility 5 (2)
private clinic 5 (2)
provincial hospital 5 (2)
outside Zimbabwe 2 (<1)
Referral site location (n=212)
Urban 82 (39)
Rural 123 (58)
prison facility 5 (2)
outside Zimbabwe 2 (<1)





NB: Percentages may not always add up to 100 because of the rounding
off error.
*Variables in the table above have varying totals because missing data
was excluded.
TB = tuberculosis; DOT = directly observed treatment.
Takarinda et al. BMC Public Health 2012, 12:981 Page 4 of 8
http://www.biomedcentral.com/1471-2458/12/981and respective dates of commencing TB treatment were
used to trace these patients by district TB coordinators in
their district TB registers.
Statistical analysis
Patient information on the data collection forms was
coded and single-entered electronically into Epidata ver-
sion 3.1 (The Epidata Association, Odense Denmark).
The data were then exported to Stata version 10 (Stata
Corporation, College Station, Texas) for data cleaning
and statistical analysis. Medians and inter-quartile ranges
were calculated for skewed continuous variables whilst
proportions were generated for categorical variables.
Time between date of transfer out from the district and
arrival at a health facility in Harare was calculated by
subtracting the transfer out date written on the transfer-
out slip from the TB registration date recorded in the TB
register of the receiving infectious disease hospital in
Harare City. Comparisons between proportions was done
using the chi-square test or alternatively the Fischers
Exact test and Odds ratios (OR) with their 95% confi-
dence intervals. Levels of significance were set at 0.05.
Ethics
Ethics approval was granted locally by the Medical
Research Council of Zimbabwe and the International
Union Against Tuberculosis and Lung Disease (The
Union). Confidentiality of information drawn from the
patient records was ensured by excluding the patient
names during data collection whilst all data collection
forms were kept in a safe and secure place accessible
only to the investigator.
Results
Proportion of TB patients registered as transfer-in
There were 7,472 patients registered with TB, of whom
263 (3.5%) were recorded as transfer-in.
Characteristics and treatment outcomes of transfer-in
patients
Demographic and clinical characteristics of transfer-in
patients in comparison to the non-transfer cohort are
shown in Table 1. More of the patients who transferred
into Harare City health department were males (N=148,
56%). The overall median age among these patients
was 33 years (IQR, 26–40), with no differences between
males and females, 34 years (IQR, 26–41) versus 30 years
(IQR, 24–38), p=0.142 respectively. Most transfer-in
patients, (N=222, 87%) had new TB, and of these 190
(88%) had pulmonary TB (PTB) of whom 67 (35%)
patients were smear-positive. “Retreatment others” were
the most common type of previously treated TB. There
was a significantly greater proportion of previouslytreated patients among the transfers-in (13%) in com-
parison to non transfer-in patients (8.4%), p=0.016.
Of the 232 (95%) patients in whom an HIV test had
been performed, 163 (71%) were HIV-positive. Of these,
143 (89%) were documented to be on CPT, but only
38 (23%) were documented as accessing ART during
TB treatment. In comparison to non transfer-in patients,
a greater proportion of transfer-in patients were HIV
tested (95% vs. 63.9%, p<0.01), however a lesser propor-
tion were diagnosed HIV-positive; 71% vs. 84%, p<0.01.
Characteristics of the transfer process for transfer-in
TB patients are shown in Table 2. Data were not avail-
able for a variable number of patients according to the
field of enquiry. Of the 176 patients with data on time
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transfer-in TB patients arrived in Harare within one
week of transfer from their referral districts. The median
time between transfer-out and transfer-in was 8 days
(IQR, 4–20 days). At the time of transfer-out, 159 (74%)
patients were in the intensive phase of TB treatment.
The majority of patients, 123 (58%) were transferred-out
from rural health facilities, of whom 88 (71%) were from
mission (faith-based) hospitals. Two patients were com-
menced on TB treatment outside the country.
Figure 1 shows the referral cascade of transfer-in TB
patients within Harare city. Patient files of all 263
transfer-in patients were taken from the records section
at the infectious disease hospital in which they were
registered. Of the 244 patients with documented referral
to the DOT municipal clinic, 157 (64%) had their TB
treatment outcomes recorded in the patient files. Of
the 87 with missing treatment outcomes, a follow-up
was conducted to the DOT centre to which they
were referred, but only 42 (48%) were registered in the
DOT registers.
Treatment outcomes of transfer-in TB patients and in
relation to sex, age, type of TB, type of referral health
facility and treatment phase of anti-TB treatment are
shown in Table 3. Overall, 69% of patients successfully
completed treatment, 10% had default/death/failure/or
transfer-out again and in 21% of patients the treatment
outcomes were not evaluated. Although there was some
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Figure 1 Referral cascade of TB patients transferred into Harare City
Observed Treatment.of transfer-in patients, the only significant comparison
was that better treatment success was experienced by
new patients who transferred-in compared with retreat-
ment patients (OR 2.6, 95% CI, 1.3 – 5.5, p < 0.01).
Treatment outcomes of transfer-in TB patients com-
pared to those of the non transfer-in cohort are shown
in Table 4. There was a lower proportion of treatment
success among the transfer-in patients (69%) when com-
pared to non transfer-in patients (83%) as there were
more patients with missing treatment outcomes among
the transfers-in (27% vs. 8%, p<0.01).
Communication of treatment outcomes of transfer-in
patients back to referring districts
There were 225 of the 263 patients documented as being
transferred in from 42 referring health facilities. Of
these, there were only 3 (1.3%) patients who had treat-
ment outcomes notified back at the referring health fa-
cility. For these 3 patients, the distance between the
transfer-out and transfer-in facility was between 41 and
150 Km, the referring facilities were all rural and the
3 patients had successfully completed treatment.
Discussion
This study, the first of its kind in Zimbabwe, shows that
although a small proportion of patients transferred-in to
Harare city out of the total number of patients regis-
tered, the management according to guidelines was poor
with only 1.3% of treatment outcomes being notifiedts transferred into 
 health department 
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submitted from DOT 
centre
8/19 (42%)
health department (Jan-Dec 2010). NB: DOT = Directly
Table 3 Treatment outcomes of Transfer-in TB patients in relation to health facility and clinical characteristics
Characteristic* (N=263) TB treatment outcomes n (%) p-value**
Treatment
success




Overall 181 (69) 5 (2) 7 (3) 0 (0) 14 (5) 56 (21) -
Sex (n = 263)
Male 100 (68) 2 (1) 4 (3) 0 (0) 9 (6) 33 (22) 0.897
Female 81 (70) 3 (3) 3 (3) 0 (0) 5 (4) 23 (20)
Age group (n = 260)
<15 16 (76) 0 (0) 0 (0) 0 (0) 1 (5) 4 (19) 0.972
15-24 26 (72) 0 (0) 1 (3) 0 (0) 0 (0) 9 (25)
25-44 108 (68) 4 (3) 5 (3) 0 (0) 10 (6) 33 (21)
45-54 18 (69) 0 (0) 1 (4) 0 (0) 2 (8) 5 (19)
≥55 11 (64) 1 (6) 0 (0) 0 (0) 1 (6) 4 (24)
Type of TB (n = 256)
New 161 (73) 4 (2) 5 (2) 0 (0) 9 (4) 43 (19) 0.026
retreatment 17 (50) 1 (3) 2 (6) 0 (0) 5 (15) 9 (26)
Time period between transferring from district and registration in Harare City (n = 176)
< 8 days 60 (71) 3 (4) 3 (4) 0 (0) 5 (6) 14 (16) 0.477
≥8 days 69 (76) 2 (2) 0 (0) 0 (0) 4 (4) 16 (18)
Type of referral health facility (n = 212)
rural mission hospital 62 (70) 2 (2) 2 (2) 0 (0) 4 (5) 18 (20) 0.355
district hospital 39 (75) 1 (2) 1 (2) 0 (0) 1 (2) 10 (19)
municipal clinic 38 (75) 1 (2) 0 (0) 0 (0) 5 (10) 7 (14)
rural clinic 2 (50) 0 (0) 0 (0) 0 (0) 2 (50) 0 (0)
prison facility 2 (40) 0 (0) 1 (20) 0 (0) 0 (0) 2 (40)
provincial hospital 4 (80) 0 (0) 1 (20) 0 (0) 0 (0) 0 (0)
private clinic 2 (40) 0 (0) 0 (0) 0 (0) 0 (0) 3 (60)
Outside Zimbabwe 1 (50) 0 (0) 0 (0) 0 (0) 0 (0) 1 (50)
Distance to referral health facility from Harare City (km) (n = 211)
≤ 40 27 (60) 1 (2) 1 (2) 0 (0) 5 (11) 11 (24) 0.179
41 – 150 51 (74) 2 (3) 1 (1) 0 (0) 0 (0) 15 (22)
151 – 300 48 (73) 1 (2) 3 (5) 0 (0) 4 (6) 10 (15)
>300 24 (77) 0 (0) 0 (0) 0 (0) 3 (10) 4 (13)
Treatment phase at time of transfer from referral health facility (n = 263)
initiation phase 112 (70) 5 (3) 3 (2) 0 (0) 11 (7) 28 (18) 0.053
continuation phase 42 (74) 0 (0) 0 (0) 0 (0) 1 (2) 14 (25)
Missing 27 (57) 0 (0) 4 (9) 0 (0) 2 (4) 14 (30)
NB: Percentages may not always add up to 100 because of rounding off error.
*Variables in the table above have varying totals because missing data was excluded.
** P-values are for the Fischers Exact test for associations between TB treatmement outcomes and clinical and health facility characteristics.
DOT = Directly Observed Treatment.
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had new pulmonary TB, had largely been HIV-tested
and had a high HIV-prevalence rate, not very different
from the non transfer-in patients in Harare city and in
general among patients in Zimbabwe that have previ-
ously been reported on [8,9].
Important lessons emerge from this study which can
inform patient management. Most of the patients for
whom there were data had transferred-in during theintensive phase of treatment, with 52% taking more than
1 week to transfer-out and transfer-in. For the 10% of
patients in whom the transfer process takes longer, it is
important that district TB officers ensure that the
patients travel with an adequate supply of oral anti-TB
drugs so that treatment is not interrupted. Although
transfer-in retreatment patients were small in number,
their management nevertheless is more complicated. The
intensive phase of treatment necessitates intramuscular
Table 4 Treatment outcomes of Transfer-in TB patients in
comparison to the non Transfer-in cohort
TB treatment
outcome





Cured 58 (22.1) 1769 (25.3) 0.581
Treatment completed 123 (46.8) 4007 (57.3) 0.020
Defaulters 5 (1.9) 105 (1.5) 0.943
Deaths 7 (2.7) 585 (8.4) 0.588
Treatment failure 0 (0) 19 (0.3) -
Not evaluated 70 (26.6) 525 (7.5) <0.01
NB: Percentages may not always add up to 100 because of rounding off error.
*TB treatment outcomes were reported for only 7,010 non transfer-in patients
out of 7,029 patients notified in Harare City for 2010 as obtained from the
Zimbabwe National TB Programme.
** P-values are for the Fischers Exact test for associations.
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prudent if these patients remained in their original treat-
ment unit until the course of injections has been com-
pleted. Interruption of treatment is a potent cause of
drug-resistance [10] and must be avoided at all costs.
Many patients transferred from long distances, often
rural mission hospitals, and TB officers need to ensure
that patients can afford their travel and are again well
covered with the necessary drugs in case of travel delays
or mishaps. Why such high numbers transfer-in from
rural mission hospitals is not certain but may reflect
many persons’ perception that church-related health ser-
vices are of better quality than those run by government,
and once patients feel better on anti-TB treatment they
decide to return to their urban public health services for
continuation of therapy [11].
Treatment outcomes of patients who transferred-in
were rather similar to the non transfer-in cohort and to
those reported from patients registered in their original
units [8,9], although there was a high proportion of
patients not evaluated and with missing outcomes. The
reasons for this are unclear, but may relate to poor
documentation in registers and treatment cards or death,
lost-to-follow-up and further transfer-outs which are not
reported to the health facilities. Whatever the reasons,
this is unsatisfactory and needs correction.
Finally, the majority of transfer-in TB patient did not
have their outcomes communicated to their referral dis-
tricts. This means the referring units would report these
patients as “transfer-out”, while they could report on
true outcomes if only communication had occurred. The
conventional means of communication has been in the
past through submission of treatment outcome request
forms by the referral districts to the receiving districts
through the postal system. Reasons for not communicat-
ing TB treatment outcomes are unclear. However, anec-
dotal reports have often attributed this to a shortage of
TB treatment outcome request forms coupled with poorperceptions of postal services in Zimbabwe by health
workers which are perceived as inconvenient, unreliable
and an outdated mode of communication. There is
therefore a need to move with the times and for the
TB Control Programme to consider new cheap and feas-
ible communication strategies such as use of a toll-free
number for use by health-workers to their mobile
phones [12].
There has been very little previous published work on
the issue of transfer-in and transfer-out in TB patients.
One study in Malawi showed that it was very common
for TB patients to transfer-out, but the procedures for
transferring–in and matching the two sets of patients
was very poor [13]. This is an area in need of improve-
ment. The strengths of this study were that a large
number of patients were evaluated and the work was
done through the routine system.
Study limitations included the usual problem of com-
pleteness and accuracy of routinely recorded programme
data and the fact that patients with unevaluated out-
comes could not be traced to their respective physical
addresses in order to establish their true outcomes.
Comparison data on the non transfer-in patients were
also obtained as aggregate data from national reports
and could not be verified or authenticated.Conclusions
In conclusion, there is need to devise better strategies of
following up TB patients to their referral DOT centres
from TB diagnosing centres to ensure that they arrive
promptly and on time with drugs supplies uninterrupted.
There is a need to improve on recording and reporting
of information and this can be done through training
and supervision. Use of mobile phones and other tech-
nology to communicate TB treatment outcomes back to
the referral districts would seem the obvious way to
move forward on this issue.
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